Eterna Therapeutics
ERNA
6 hedge funds and large institutions have $318K invested in Eterna Therapeutics in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
36% less capital invested
Capital invested by funds: $499K → $318K (-$181K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$30.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$48K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$30.1K |
| 3 |
Renaissance Technologies
New York
|
-$30.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $167K | -$30.1K | -1 | -13% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $36K | – | – | – |
|
|
NSIM
3
North Star Investment Management
Chicago,
Illinois
| $32K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $28K | – | – | – |
|
|
5
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $26K | -$30.1K | -1 | -50% |
|
|
VF
6
Virtu Financial
New York
| $23K | +$30.1K | +1 | New |
|
7
BlackRock
New York
| $6K | – | – | – |
|
|
8
Jane Street
New York
| – | -$48K | -1 | Closed |
|
ERNA Hedge Fund Activity: Q3 2020 in Review
6 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q3 2020, worth a combined $318K — down 36% from $499K a quarter earlier.
Fund positioning in ERNA was balanced in Q3 2020: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $30.1K. The largest seller was Jane Street, exiting entirely with an estimated $48K sold.
- 6 institutional investors held Eterna Therapeutics (ERNA) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $318K of Eterna Therapeutics stock for Q3 2020, down 36% quarter-over-quarter.
- 1 fund opened new Eterna Therapeutics positions in Q3 2020 and 1 closed out, a net change of 0 holders.
- The largest Eterna Therapeutics buyer in Q3 2020 was Virtu Financial, an estimated $30.1K added.
- The largest Eterna Therapeutics seller in Q3 2020 was Jane Street, an estimated $48K sold.
Based on aggregated 13F filings for Q3 2020.